Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study

Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study

The PACIFIC trial led to a new standard of care for patients with locally advanced lung cancer, but real-world practice has demonstrated that immune checkpoint inhibitor (ICI) pneumonitis can lead to significant clinical complications. This study aimed to examine the clinical predictors, outcomes, a...

Full description

Bibliographic Details
Main Authors: Chloe Ahryung Lim, Sunita Ghosh, Hali Morrison, Daniel Meyers, Igor Stukalin, Marc Kerba, Desiree Hao, Aliyah Pabani
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Current Oncology
Subjects:
durvalumab-associated pneumonitis
immunotherapy toxicity
radiation pneumonitis
Online Access:https://www.mdpi.com/1718-7729/30/12/757

Internet

https://www.mdpi.com/1718-7729/30/12/757

Similar Items